Sihuan Pharmaceutical (00460): The innovative drug Xuan Yuening® was included in the national basic medical insurance drug catalogue for the first time

Zhitongcaijing · 2d ago

Zhitong Finance App News, Sihuan Pharmaceutical (00460) announced that the innovative drug pyroxil tablets (trade name: Xuan Yuening®) independently developed by Xuanzhu Biotechnology Co., Ltd. (Xuanzhu Biology), a non-wholly-owned subsidiary of the Group, was included for the first time in the “National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalogue (2025)” (2025 National Basic Medical Insurance Catalogue). The 2025 national basic health insurance catalogue will be officially implemented on January 1, 2026.

The results of this medical insurance negotiation will help Xuanzhu Biotech to further improve the affordability and accessibility of Xuanyue Ning® among patients, further promote the drug's marketing and increase sales scale, and have a positive impact on the long-term business development of Xuanzhu Biotech. Xuanzhu Biotech will actively cooperate to promote the implementation of health insurance policies, continue to promote hospital access, expand core markets and broad market coverage, so as to continuously improve patients' access to medication.